Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Pharmaceuticals
Teva Pharmaceuticals CEO Talks "Trough Year", 2020 Turnaround
Teva's CEO explains why 2019 is a trough year for the Israeli pharma company.
Exelixis Rises as Fourth-Quarter Earnings Beat Estimates
The company reports fourth-quarter earnings above analysts' forecasts amid strong revenue from collaboration agreements and royalty payments to distribute its drugs.
Teva Pharma Tumbles as Earnings and Outlook Miss Estimates
Teva posts a fourth-quarter earnings miss and issues lower-than-expected guidance for 2019.
Gilead Sciences Falls on Failed Cirrhosis Drug Trial of Selonsertib
Gilead Sciences says Selonsertib, a new drug for treating NASH, a type of liver disease, failed Phase 3 trials.
NuVasive Stock Surges on Report of Smith & Nephew Interest
Shares surge after a report says London-based Smith & Nephew is considering buying the company.
FDA Cracks Down On Misleading Dietary Supplements
The agency delivers 17 different warnings to companies advertising that their supplements help treat Alzheimer's, diabetes and cancer.
Gilead Sciences Drops Following Earnings Miss
The biotech company reports downside bottom-line results, though it beats on revenue.
Merck Is Named No. 1 Pharma Pick at Bank of America
Strong sales of key cancer treatment drug Keytruda are expected to continue to drive revenues and earnings.
Eli Lilly Is Trading Strong Ahead of Earnings on Wednesday
Jim Cramer said that Eli Lilly was the best of the pharmaceutical companies as he looked at the companies reporting earnings this week.
Cigna Shares Fall Despite Strong Earnings
Cigna reports quarterly earnings above forecasts but full-year guidance below analysts' expectations.